Figure 1: Western Blot - Anti-MEF2A Antibody (A95841)
Western blot analysis of lysates from NIH/3T3 cells, treated with PMA using Anti-MEF2A Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using Anti-MEF2A Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.